BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.00K | 26.00K | 40.00K | 39.00K | 40.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.00K | 26.00K | 40.00K | 39.00K | 40.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 13.00K | 26.00K | 40.00K | 39.00K | 40.00K |
| SG&A Expenses | 26.58M | 11.70M | 11.63M | 15.47M | 15.52M |
| Depreciation & Amortization | 636.00K | 131.00K | 188.00K | 251.00K | 312.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.50M | 12.44M | 12.65M | 17.63M | 18.73M |
| Operating Income | -27.48M | -12.41M | -12.61M | -17.59M | -18.69M |
| Income Before Tax | -26.18M | -9.72M | -10.34M | -15.37M | -17.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.18 | -9.72 | -10.34 | -15.37 | -17.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.00K | -16.00K | 9.00K | 88.00K | -429.00K |
| Net Income | -26.20M | -9.74M | -10.33M | -15.28M | -17.93M |
| EBIT | -27.48M | -12.41M | -12.61M | -17.59M | -18.69M |
| EBITDA | -26.84M | -12.28M | -12.42M | -17.34M | -18.38M |
| EPS Basic | -1.06 | -0.62 | -0.85 | -1.48 | -1.97 |
| Normalized Basic EPS | -0.71 | -0.50 | -0.61 | -1.00 | -1.29 |
| EPS Diluted | -1.06 | -0.62 | -0.85 | -1.48 | -1.97 |
| Normalized Diluted EPS | -0.71 | -0.50 | -0.61 | -1.00 | -1.29 |
| Average Basic Shares Outstanding | 81.85M | 67.06M | 56.13M | 47.66M | 38.99M |
| Average Diluted Shares Outstanding | 81.85M | 67.06M | 56.13M | 47.66M | 38.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |